Consistent with our findings, CD70 clustering can initiate reverse signaling through its cytoplasmic tail, engaging PI3K/AKT, MAPK and NF-κB pathways that promote proliferation, EMT, invasion, and immune-evasive phenotypes in tumor models (10, 14–16) (51–53). The gene discussed is AKT1; the disease is neoplasm.